Ischemic Heart Disease: An Update

Rebekka Vibjerg Jensen1, Marie Vognstoft Hjortbak1, Hans Erik Bøtker1

  • 1Department of Cardiology, Aarhus University Hospital, Aarhus N, Denmark.

Insights

Ischemic heart disease management is evolving with new diagnostic tools like coronary CT angiography and functional imaging. Optimal medical treatment and FFR-guided revascularization improve outcomes for patients with coronary artery disease.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Atherosclerosis Research

Background:

  • Ischemic heart disease (IHD) involves coronary artery atherosclerosis or functional circulation changes.
  • IHD management includes lifestyle changes, medications, and revascularization, potentially stabilizing or regressing the disease.
  • New classifications distinguish between acute coronary syndrome and chronic coronary syndrome.

Purpose of the Study:

  • To review current diagnostic and treatment strategies for ischemic heart disease.
  • To highlight the role of noninvasive imaging in diagnosing coronary artery disease.
  • To emphasize the importance of optimal medical treatment and FFR-guided revascularization.

Main Methods:

  • Review of current literature and clinical guidelines for ischemic heart disease diagnosis and management.
  • Focus on noninvasive imaging modalities such as coronary computed tomography (CT) angiography.
  • Discussion of functional assessments including nuclear, MRI, and CT-based fractional flow reserve (FFR-CT).

Main Results:

  • Coronary CT angiography is a first-line diagnostic tool in suitable patients, offering high diagnostic accuracy.
  • Noninvasive functional or anatomic imaging is recommended for symptomatic patients when obstructive disease is suspected.
  • FFR-guided myocardial revascularization offers symptom relief and prognostic benefits for non-responsive patients.

Conclusions:

  • Optimal medical treatment is crucial for managing ischemic heart disease.
  • Advanced noninvasive imaging, particularly coronary CT angiography with FFR-CT, enhances diagnostic capabilities.
  • Personalized treatment strategies, including FFR-guided revascularization, improve patient outcomes and reduce myocardial infarction risk.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.6K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
283
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
294
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
230
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
180
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
221